Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company · London

Orchard Therapeutics (Europe) Limited

Research and experimental development on biotechnology

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Orchard Therapeutics (Europe) Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 14

  1. Takeyoshi Yamashita 2025-2026 Director View profile
  2. Elise Wang 2018-2018 Director View profile
  3. Joanne Beck 2018-2018 Director View profile
  4. Marc Dunoyer 2018-2018 Director View profile
  5. James A Geraghty 2018-2018 Director View profile
  6. Charles Rowland Jr 2018-2018 Director View profile
  7. John Edward Ilett 2018-2022 Director View profile
  8. Martin Andrews 2018-2018 Director View profile
  9. Hong Fang Song 2017-2018 Director View profile
  10. Mark Rothera 2017-2020 Director View profile
  11. Dr Helen Wise 2016-2016 Director View profile
  12. Chris Williams 2016-2016 Director View profile
  13. Benjamin Adam Auspitz 2016-2018 Director View profile
  14. Dr Alexander Pasteur 2015-2018 Director View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology
Incorporated
02/09/2015
Registered office
London
Previous names
Orchard Therapeutics Limited (until 29/10/2018)
Newincco 1387 Limited (until 03/11/2015)

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Orchard Therapeutics (Europe) Limited is controlled by Kyowa Kirin International PLC
    Evidence
    active 75-100% shares · notified 2025-09-10 · source: Companies House PSC register

Ultimately controlled by Kyowa Kirin International PLC.

10 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Grants received

1 grant · £408,885 total

360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.

Top funders

  • Department for Business, Energy and Industrial Strategy · £408,885

Most recent

  • Department for Business, Energy and Industrial Strategy £408,8852019-04-01
Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

4 directors on the board

5y median 4.4y
average tenure
10.4y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (3)

Portfolio (1)

0
also govern a charity

Left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together
  • No director brings board experience from anywhere else
  • Narrow spread of sectors across the board

Where to look Suggested search: succession planning for long-tenured seats; a director with board experience elsewhere.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
09759506
Status
Active
Type
Private Limited Company
Accounts next due
30/09/2026
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data